Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 12 | 2019 | 1063 | 1.600 |
Why?
|
| Exercise | 13 | 2019 | 591 | 1.350 |
Why?
|
| Caloric Restriction | 4 | 2019 | 92 | 1.190 |
Why?
|
| Aging | 6 | 2017 | 881 | 1.020 |
Why?
|
| Aged | 32 | 2020 | 9487 | 0.980 |
Why?
|
| Adipose Tissue | 4 | 2011 | 327 | 0.800 |
Why?
|
| Pericardium | 2 | 2011 | 50 | 0.800 |
Why?
|
| Resistance Training | 3 | 2016 | 70 | 0.770 |
Why?
|
| Dietary Proteins | 1 | 2020 | 50 | 0.770 |
Why?
|
| Exercise Therapy | 5 | 2019 | 229 | 0.760 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 101 | 0.730 |
Why?
|
| Abdominal Fat | 3 | 2018 | 46 | 0.680 |
Why?
|
| Body Composition | 6 | 2019 | 365 | 0.670 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2018 | 2 | 0.660 |
Why?
|
| Scavenger Receptors, Class E | 2 | 2008 | 2 | 0.660 |
Why?
|
| Life Style | 3 | 2018 | 364 | 0.650 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 37 | 0.640 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 44 | 0.640 |
Why?
|
| Female | 31 | 2020 | 18164 | 0.630 |
Why?
|
| Exosomes | 1 | 2018 | 38 | 0.620 |
Why?
|
| Postmenopause | 2 | 2011 | 397 | 0.620 |
Why?
|
| Inflammation | 3 | 2010 | 507 | 0.610 |
Why?
|
| Adiposity | 4 | 2016 | 191 | 0.600 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2018 | 105 | 0.590 |
Why?
|
| Geriatrics | 1 | 2018 | 94 | 0.590 |
Why?
|
| Humans | 36 | 2020 | 29093 | 0.580 |
Why?
|
| Male | 29 | 2020 | 17807 | 0.580 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2011 | 1079 | 0.540 |
Why?
|
| Vascular Diseases | 1 | 2015 | 61 | 0.520 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 312 | 0.510 |
Why?
|
| Neurons | 1 | 2018 | 394 | 0.500 |
Why?
|
| Hypertension | 5 | 2017 | 906 | 0.480 |
Why?
|
| Electrocardiography | 1 | 2018 | 562 | 0.470 |
Why?
|
| Middle Aged | 17 | 2019 | 10829 | 0.450 |
Why?
|
| Coronary Circulation | 2 | 2016 | 30 | 0.450 |
Why?
|
| Physical Fitness | 3 | 2010 | 119 | 0.430 |
Why?
|
| Myocardium | 2 | 2016 | 170 | 0.420 |
Why?
|
| Atherosclerosis | 3 | 2015 | 693 | 0.420 |
Why?
|
| Lipoprotein Lipase | 1 | 2011 | 14 | 0.410 |
Why?
|
| Lipoproteins, VLDL | 1 | 2011 | 27 | 0.410 |
Why?
|
| Lipase | 1 | 2011 | 28 | 0.410 |
Why?
|
| C-Reactive Protein | 4 | 2017 | 232 | 0.390 |
Why?
|
| Brain | 1 | 2018 | 930 | 0.390 |
Why?
|
| Aged, 80 and over | 10 | 2017 | 3717 | 0.390 |
Why?
|
| Body Mass Index | 6 | 2019 | 865 | 0.380 |
Why?
|
| Blood Pressure | 3 | 2015 | 804 | 0.380 |
Why?
|
| Exercise Tolerance | 4 | 2019 | 110 | 0.380 |
Why?
|
| Ginkgo biloba | 1 | 2010 | 19 | 0.370 |
Why?
|
| Nitric Oxide | 2 | 2009 | 116 | 0.360 |
Why?
|
| Nitrites | 1 | 2009 | 20 | 0.360 |
Why?
|
| Nitrates | 1 | 2009 | 25 | 0.360 |
Why?
|
| Plant Extracts | 1 | 2010 | 60 | 0.350 |
Why?
|
| Lipoproteins, HDL | 1 | 2011 | 247 | 0.340 |
Why?
|
| Lipoproteins, LDL | 1 | 2009 | 77 | 0.340 |
Why?
|
| Aorta | 1 | 2009 | 103 | 0.330 |
Why?
|
| Comorbidity | 1 | 2009 | 540 | 0.300 |
Why?
|
| Logistic Models | 3 | 2018 | 727 | 0.290 |
Why?
|
| Heart Failure | 3 | 2018 | 568 | 0.280 |
Why?
|
| Interleukin-6 | 3 | 2012 | 225 | 0.260 |
Why?
|
| Exercise Test | 4 | 2019 | 194 | 0.250 |
Why?
|
| Sex Factors | 2 | 2017 | 631 | 0.250 |
Why?
|
| Age Factors | 3 | 2018 | 1108 | 0.210 |
Why?
|
| Gait | 3 | 2017 | 115 | 0.200 |
Why?
|
| Cardiovascular Diseases | 3 | 2017 | 1013 | 0.200 |
Why?
|
| Oxygen Consumption | 4 | 2019 | 138 | 0.200 |
Why?
|
| Polymorphism, Genetic | 2 | 2014 | 196 | 0.190 |
Why?
|
| North Carolina | 3 | 2015 | 1423 | 0.190 |
Why?
|
| Hand Strength | 2 | 2012 | 85 | 0.190 |
Why?
|
| Weight Loss | 2 | 2015 | 413 | 0.190 |
Why?
|
| Proteins | 1 | 2020 | 140 | 0.180 |
Why?
|
| Chronic Disease | 3 | 2010 | 369 | 0.180 |
Why?
|
| Intra-Abdominal Fat | 3 | 2018 | 61 | 0.170 |
Why?
|
| Risk Factors | 7 | 2017 | 3531 | 0.170 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 637 | 0.170 |
Why?
|
| Mobility Limitation | 3 | 2014 | 187 | 0.170 |
Why?
|
| Sepharose | 1 | 2018 | 5 | 0.160 |
Why?
|
| Biotinylation | 1 | 2018 | 10 | 0.160 |
Why?
|
| Body Fat Distribution | 1 | 2018 | 34 | 0.160 |
Why?
|
| Research | 1 | 2018 | 72 | 0.160 |
Why?
|
| Geriatric Assessment | 4 | 2016 | 355 | 0.160 |
Why?
|
| Protein Binding | 1 | 2018 | 199 | 0.160 |
Why?
|
| Treatment Outcome | 3 | 2019 | 3099 | 0.160 |
Why?
|
| Cell Separation | 1 | 2018 | 86 | 0.160 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 77 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2018 | 1218 | 0.160 |
Why?
|
| Time Factors | 2 | 2015 | 2001 | 0.150 |
Why?
|
| Disability Evaluation | 2 | 2019 | 211 | 0.150 |
Why?
|
| Avitaminosis | 1 | 2017 | 2 | 0.150 |
Why?
|
| Vitamin K 1 | 1 | 2017 | 11 | 0.150 |
Why?
|
| Heart | 1 | 2018 | 161 | 0.150 |
Why?
|
| Lysine | 1 | 2017 | 24 | 0.150 |
Why?
|
| Gene Expression | 1 | 2018 | 332 | 0.150 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2016 | 24 | 0.140 |
Why?
|
| Dobutamine | 1 | 2016 | 43 | 0.140 |
Why?
|
| Stroke Volume | 1 | 2018 | 278 | 0.140 |
Why?
|
| Elasticity | 1 | 2015 | 34 | 0.140 |
Why?
|
| African Continental Ancestry Group | 1 | 2017 | 350 | 0.130 |
Why?
|
| Continental Population Groups | 1 | 2017 | 221 | 0.130 |
Why?
|
| Ankle Brachial Index | 1 | 2015 | 37 | 0.130 |
Why?
|
| Waist Circumference | 1 | 2015 | 89 | 0.130 |
Why?
|
| Heart Ventricles | 1 | 2016 | 107 | 0.130 |
Why?
|
| European Continental Ancestry Group | 2 | 2017 | 1131 | 0.130 |
Why?
|
| Forecasting | 1 | 2015 | 133 | 0.130 |
Why?
|
| Heart Rate | 1 | 2017 | 315 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2017 | 173 | 0.130 |
Why?
|
| Single-Blind Method | 2 | 2012 | 165 | 0.120 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2014 | 35 | 0.120 |
Why?
|
| Forced Expiratory Volume | 1 | 2014 | 112 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 525 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2015 | 469 | 0.120 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 494 | 0.120 |
Why?
|
| Triglycerides | 2 | 2011 | 214 | 0.120 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2014 | 142 | 0.110 |
Why?
|
| Activities of Daily Living | 2 | 2014 | 238 | 0.110 |
Why?
|
| Gene Frequency | 2 | 2014 | 225 | 0.110 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2012 | 9 | 0.110 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 70 | 0.110 |
Why?
|
| Perfusion | 1 | 2011 | 64 | 0.100 |
Why?
|
| DNA Primers | 1 | 2011 | 87 | 0.100 |
Why?
|
| Case-Control Studies | 2 | 2018 | 859 | 0.100 |
Why?
|
| Linear Models | 2 | 2010 | 426 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 148 | 0.100 |
Why?
|
| Base Sequence | 1 | 2011 | 240 | 0.100 |
Why?
|
| Hemodynamics | 1 | 2011 | 148 | 0.100 |
Why?
|
| Genotype | 2 | 2014 | 735 | 0.100 |
Why?
|
| Aortic Diseases | 1 | 2011 | 54 | 0.100 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 72 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2009 | 223 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2015 | 2019 | 0.090 |
Why?
|
| Coronary Disease | 1 | 2011 | 200 | 0.090 |
Why?
|
| Plethysmography | 1 | 2009 | 13 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2015 | 1305 | 0.090 |
Why?
|
| Multienzyme Complexes | 1 | 2009 | 8 | 0.090 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2009 | 10 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1379 | 0.090 |
Why?
|
| Blood Flow Velocity | 1 | 2009 | 59 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 2108 | 0.090 |
Why?
|
| Absorptiometry, Photon | 2 | 2019 | 129 | 0.080 |
Why?
|
| Probability | 1 | 2009 | 150 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 501 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2010 | 170 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2011 | 1687 | 0.080 |
Why?
|
| Exons | 1 | 2008 | 49 | 0.080 |
Why?
|
| Thinness | 1 | 2008 | 31 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 207 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 200 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2008 | 90 | 0.080 |
Why?
|
| Lipids | 1 | 2009 | 209 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 532 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 120 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 1356 | 0.080 |
Why?
|
| Incidence | 1 | 2010 | 1119 | 0.070 |
Why?
|
| Kidney | 1 | 2010 | 485 | 0.070 |
Why?
|
| Body Weight | 1 | 2008 | 290 | 0.070 |
Why?
|
| Overweight | 1 | 2008 | 256 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2016 | 3111 | 0.070 |
Why?
|
| Subcutaneous Fat, Abdominal | 2 | 2018 | 13 | 0.070 |
Why?
|
| Adult | 2 | 2011 | 8420 | 0.050 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 339 | 0.050 |
Why?
|
| Health Education | 2 | 2014 | 121 | 0.050 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 111 | 0.040 |
Why?
|
| Executive Function | 1 | 2019 | 54 | 0.040 |
Why?
|
| Fatigue | 1 | 2019 | 68 | 0.040 |
Why?
|
| Thigh | 1 | 2018 | 39 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 379 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2018 | 139 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 45 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 40 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 466 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2017 | 83 | 0.040 |
Why?
|
| Calcinosis | 1 | 2017 | 143 | 0.030 |
Why?
|
| Echocardiography, Stress | 1 | 2016 | 22 | 0.030 |
Why?
|
| Coronary Stenosis | 1 | 2016 | 28 | 0.030 |
Why?
|
| Microcirculation | 1 | 2016 | 61 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 44 | 0.030 |
Why?
|
| Cognition | 1 | 2019 | 526 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 709 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 145 | 0.030 |
Why?
|
| Spirometry | 1 | 2014 | 32 | 0.030 |
Why?
|
| Brachial Artery | 1 | 2014 | 66 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 242 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 412 | 0.030 |
Why?
|
| Stroke | 1 | 2017 | 545 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 64 | 0.020 |
Why?
|
| Dinoprost | 1 | 2009 | 10 | 0.020 |
Why?
|
| Nitrogen Oxides | 1 | 2009 | 5 | 0.020 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2009 | 26 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 43 | 0.020 |
Why?
|
| Antioxidants | 1 | 2009 | 114 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 454 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2009 | 157 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 464 | 0.020 |
Why?
|
| United States | 1 | 2015 | 3630 | 0.020 |
Why?
|
| Health Status | 1 | 2008 | 368 | 0.020 |
Why?
|
| Animals | 1 | 2010 | 7297 | 0.010 |
Why?
|